Skip to content
10-Q

Quarterly Report

HELICOS BIOSCIENCES CORP

0001104659-12-036936

← back to feed
Filed
May 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 7, 2012 87.2M sh
Shares Diluted Q1 2012 · Mar 31, 2012 86.85M sh
Shares Diluted Q1 2012 · Mar 31, 2011 84.92M sh
Capex Q1 2012 · Mar 31, 2012 $0
Capex Q1 2012 · Mar 31, 2012 $9.54M
Short Term Debt Q1 2012 · Mar 31, 2012 $2.52M
Short Term Debt Q1 2012 · Dec 31, 2011 $3.15M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $130K
Cash And Equivalents Q1 2012 · Dec 31, 2011 $999K
Cash And Equivalents Q1 2012 · Mar 31, 2011 $2.91M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $2.51M
Stockholders Equity Q1 2012 · Mar 31, 2012 −$11.85M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$10.94M
Current Liabilities Q1 2012 · Mar 31, 2012 $13.42M
Current Liabilities Q1 2012 · Dec 31, 2011 $13.48M
Total Liabilities Q1 2012 · Mar 31, 2012 $13.47M
Total Liabilities Q1 2012 · Dec 31, 2011 $13.5M
Current Assets Q1 2012 · Mar 31, 2012 $1.51M
Current Assets Q1 2012 · Dec 31, 2011 $2.46M
Total Assets Q1 2012 · Mar 31, 2012 $1.62M
Total Assets Q1 2012 · Dec 31, 2011 $2.56M
Sga Expense Q1 2012 · Mar 31, 2012 $1.07M
Sga Expense Q1 2012 · Mar 31, 2012 $76.14M
Sga Expense Q1 2012 · Mar 31, 2011 $982K
Rd Expense Q1 2012 · Mar 31, 2012 $329K
Rd Expense Q1 2012 · Mar 31, 2012 $113.92M
Rd Expense Q1 2012 · Mar 31, 2011 $1.15M
Net Income Q1 2012 · Mar 31, 2012 −$922K
Net Income Q1 2012 · Mar 31, 2012 −$175.04M
Net Income Q1 2012 · Mar 31, 2011 −$404K
Operating Income Q1 2012 · Mar 31, 2012 −$863K
Operating Income Q1 2012 · Mar 31, 2012 −$181.4M
Operating Income Q1 2012 · Mar 31, 2011 −$1.05M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $15K
Cost Of Revenue Q1 2012 · Mar 31, 2012 $2.2M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $98K
Revenue Q1 2012 · Mar 31, 2012 $551K
Revenue Q1 2012 · Mar 31, 2012 $12.75M
Revenue Q1 2012 · Mar 31, 2011 $1.18M
Long Term Debt Q1 2012 · Dec 31, 2011 $0